Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
about
Photosensitivity with Angiotensin II Receptor Blockers: A Retrospective Study Using Data from VigiBase(®).Antibiotic precautions in athletesPrescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohortEnvironmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.Vitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut.Photosensitivity reaction in a woman using an herbal supplement containing ginseng, goldenseal, and bee pollen.Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report.The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day.An in vivo study of free radicals generated in murine skin by protoporphyrin IX and visible light.Associations between environmental factors and incidence of cutaneous melanoma. ReviewFemale Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort.Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by use.Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis.Drug-induced photoallergic and phototoxic reactions.Use of photosensitising diuretics and risk of skin cancer: a population-based case-control studyFluoroquinolone antibiotics having the potential to interfere with fluorescence-based diagnosis.Antihypertensive drugs and lip cancer in non-Hispanic whitesRecall of indoor tanning salon warnings and safety guidelines among a national sample of tanners.Drug-induced photosensitivity: culprit drugs, management and prevention.Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.Drug-induced oxidative stress and toxicity.Drug-induced photoallergic and phototoxic reactions - an update.Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.Drug-induced skin reactions: a pathologist viewpoint.Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.The use of conjunctival ultraviolet autofluorescence (CUVAF) as a biomarker of time spent outdoors.DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib.Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.Oxidatively-generated damage to DNA and proteins mediated by photosensitized UVAPhotosensitivity reactions to vandetanib: redevelopment after sequential treatment with docetaxel.Henna tattooing dermatitis: consider an additive as the culpritExposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma.[Phototoxic and photoallergic reactions].Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man.Stepwise photosensitized thymine dimerization mediated by an exciton intermediate.Photocages for protection and controlled release of bioactive compounds.Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals.S1-Guidelines on UV phototherapy and photochemotherapy.Cutaneous Drug Reactions in the Elderly.
P2860
Q30981333-85312DD0-BB49-4B87-B850-B1188E251A60Q33786181-0CE62ADD-03CA-4030-A168-C22437F576C9Q33992415-BF3DE73D-A193-4FAC-B631-800C152566CCQ34310736-87673BEC-9A05-4B2F-8BEB-4B1CA522362FQ34491388-800A39B8-0071-41F2-B704-DCDD296F587AQ34543955-D14D7D9D-938E-4B81-8331-974E93F9F503Q35108522-A3D12DC9-4429-4313-B6C5-2372270E4B3EQ35161449-D86FEA4C-D313-4B27-BB24-CFADAC4979DCQ35843869-94ECE9D7-E822-4CCE-9E56-1C8F4C56CD85Q36072486-AD406927-AE79-459C-9218-04BAC49C3B21Q36346626-C0139A35-D264-4183-BAB1-BE5C7F46AF06Q36475477-E1A7BD97-8341-40B7-B064-0FCA5EA8B9E6Q36681795-456DC02C-F86E-4F00-AD31-4A097B8DF8B8Q36905858-0AF8F219-A2E1-4D9A-92C7-935046200E39Q36965031-34A3C74C-C845-4C09-8D00-DD6C9F773BD2Q37008961-A28564C3-8EBE-4428-BEDB-E3C039BF93A2Q37257528-4FDF4552-B0D6-4EFD-85F2-1C15C963ECA0Q37415984-5E121472-46D7-4430-823B-54325E4E8895Q37924276-BAAF20DC-52CC-4992-9EFF-E8065B43FB4DQ37950866-D5DABE00-2DBF-4BAE-8EF0-7BE90CBE24ECQ38037517-B07B93DE-78BD-486E-9D0D-A67EDA08D59DQ38189112-EB427297-9E41-471A-86CB-1E9E1CF2DB04Q38417725-F1C3F812-52DC-45B0-94DB-06D275CAFEF9Q38538208-CA4041C6-E55F-44C2-AF4C-3A9FF03A035CQ38703524-7F8F2FDD-B47E-4ADE-8BDB-87B9DF5B6C0FQ38847828-B5B24A12-0BD4-477A-ADC5-E772A7F8C580Q38938690-30726988-5721-44AA-9B14-377EBC1DCF77Q39004641-513DBEDD-4DC9-4E95-AD1A-2781B1D13DD7Q39042732-7504A4EB-8924-4021-9386-21D7A2F00E41Q41002305-9FB79DFE-AAB8-4368-8399-C88B19D9C850Q41837560-B8754A48-D9E8-4692-BB85-F8236E6F1D2BQ44666730-AC3263C2-D696-45A6-BD88-27D5860FC3E2Q44945147-C33E271C-913C-43DD-9AEC-61EEBFCF7509Q46913557-3546AE06-851C-488B-87A1-E5BEBBC096C6Q47103794-558DC0EC-2320-4EFC-9A7D-0F9F53123C2FQ48224513-9CEA994E-5929-4C19-BB7A-ED90240901C5Q48273200-B2727E4A-AFB1-409A-A622-5EA3BCE034BBQ50479304-6C10F6B3-CDD7-4106-897B-12DA79B608B7Q51206994-88331935-63CA-447D-B9F2-D276E2C9DB2DQ51803601-958B9CCF-882C-48A2-A323-5CB184647EFF
P2860
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@ast
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@en
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@nl
type
label
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@ast
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@en
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@nl
prefLabel
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@ast
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@en
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@nl
P1433
P1476
Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.
@en
P2093
Douglas E Moore
P304
P356
10.2165/00002018-200225050-00004
P577
2002-01-01T00:00:00Z
P6179
1053344610